Role of reactive oxygen species in the pathogenesis of diabetic nephropathy

Hunjoo Ha1, In-A Hwang, Jong Hee Park

  • 1College of Pharmacy and Division of Life & Pharmaceutical Sciences, Graduate School, Ewha Woman's University, Seoul, Republic of Korea.

Insights

Reactive oxygen species (ROS) contribute to diabetic complications by damaging cells and amplifying harmful signals. Strategies to control blood sugar and reduce ROS may prevent kidney disease in diabetes.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Nephrology

Background:

  • Reactive oxygen species (ROS) are increasingly implicated in the pathogenesis of diabetic complications.
  • Diabetes is characterized by increased oxidative stress and overproduction of ROS, primarily due to hyperglycemia.
  • Vascular cells, including renal cells, generate ROS under hyperglycemic conditions.

Purpose of the Study:

  • To elucidate the role of ROS in hyperglycemia-induced renal cell dysfunction and diabetic nephropathy.
  • To explore the mechanisms by which ROS contribute to the progression of kidney disease in diabetes.
  • To evaluate potential therapeutic strategies targeting ROS for the prevention of diabetic nephropathy.

Main Methods:

  • Investigated ROS generation in renal cells under hyperglycemic conditions.
  • Examined the involvement of NADPH oxidase and mitochondrial electron transport chain in ROS production.
  • Analyzed the signaling pathways activated by ROS, including transcription factors and profibrotic gene expression.
  • Evaluated the effects of glycemic control, angiotensin II inhibition, and antioxidants on diabetic nephropathy development.

Main Results:

  • Hyperglycemia leads to increased ROS production in renal cells via NADPH oxidase and mitochondrial pathways.
  • ROS act as signaling molecules, activating cascades that promote profibrotic gene expression in the kidney.
  • ROS can amplify their own signaling, exacerbating cellular damage.
  • Intensive glycemic control and angiotensin II inhibition mitigate ROS overproduction and delay diabetic nephropathy.
  • Antioxidant therapies show potential in preventing or delaying the onset of diabetic nephropathy.

Conclusions:

  • ROS play a critical role in the development and progression of diabetic nephropathy.
  • Targeting ROS production and enhancing ROS removal are promising therapeutic strategies for diabetic kidney disease.
  • Combined approaches to manage hyperglycemia and oxidative stress may effectively prevent diabetic nephropathy.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...